Does intensified cholesterol lowering provide greater protection from cardiovascular events among patients with stable coronary artery disease?
AUTOR(ES)
Hackam, Daniel G.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=557097Documentos Relacionados
- Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study
- Should women be offered cholesterol lowering drugs to prevent cardiovascular disease? Yes
- Should women be offered cholesterol lowering drugs to prevent cardiovascular disease? No
- Periodontal disease and inflammatory blood cytokines in patients with stable coronary artery disease
- Should women be offered cholesterol lowering drugs to prevent cardiovasiovasular disease?